Weight-Loss Drug Zepbound Cuts Sleep Apnea Severity

Published on April 18, 2024

Eli Lilly says its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials, paving the way for expanding use of the drug. The drug cut the frequency of irregular breathing episodes by as much as…

Read Full Article (External Site)